2021 American Society of Hematology Annual Meeting*

Download All
December 11-14, 2021; Atlanta, Georgia
Review slidesets and expert analyses of key studies from the 2021 Hematology Annual Meeting!
John M. Burke, MD
Amy E. DeZern, MD, MHS
person default
David Dingli, MD, PhD
Shaji K. Kumar, MD
Sagar Lonial, MD
Peter Martin, MD
Mark A. Schroeder, MD
Sujit Sheth, MD
B Douglas Smith
B. Douglas Smith, MD
Srdan Verstovsek, MD, PhD
Eunice S. Wang, MD

An Expert’s Guide to ASH 2021: A Preview of the Top Abstracts

Review experts’ perspectives on the most clinically relevant data on malignant and nonmalignant hematology to be presented at the ASH 2021 annual meeting, including key insights and the latest data you need to understand and integrate into your practice.

John M. Burke, MD Amy E. DeZern, MD, MHS Shaji K. Kumar, MD Sagar Lonial, MD Peter Martin, MD Mark A. Schroeder, MD Sujit Sheth, MD B Douglas Smith B. Douglas Smith, MD Srdan Verstovsek, MD, PhD Eunice S. Wang, MD Released: December 8, 2021

Acute and Chronic Leukemias

Expert faculty review and share their insights and perspectives on key studies on the management of acute and chronic leukemias presented at the Hematology 2021 annual meeting.

B Douglas Smith B. Douglas Smith, MD Eunice S. Wang, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: April 6, 2022 Expired: April 5, 2023

Lymphomas and Chronic Lymphocytic Leukemia

Expert faculty review and share their insights and perspectives on key studies on the management of lymphomas and CLL presented at the 2021 American Society of Hematology Annual Meeting.

John M. Burke, MD Peter Martin, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: May 10, 2022 Expired: May 9, 2023

Myelodysplastic Syndromes and Myeloproliferative Neoplasms

Review expert perspectives on the most clinically relevant data on myelodysplastic syndromes and myeloproliferative neoplasms presented at the 2021 ASH Annual Meeting.

Amy E. DeZern, MD, MHS Srdan Verstovsek, MD, PhD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: May 11, 2022 Expired: May 10, 2023

Multiple Myeloma

Read expert perspectives and clinical insights on the most clinically relevant data for multiple myeloma presented at the Hematology 2021 annual meeting.

Shaji K. Kumar, MD Sagar Lonial, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: May 12, 2022 Expired: May 11, 2023

Nonmalignant Hematologic Disorders

Review expert perspectives and insights on the most clinically relevant data for hemophilia, sickle cell disease, GVHD, and PNH presented at the Hematology 2021 annual meeting.

person default David Dingli, MD, PhD Mark A. Schroeder, MD Sujit Sheth, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: March 1, 2022 Expired: February 28, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
AstraZeneca
Daiichi Sankyo, Inc.
GlaxoSmithKline
Incyte Corporation
Jazz Pharmaceuticals, Inc.
Merck Sharp & Dohme Corp.
Novartis Pharmaceuticals Corporation

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings